Stay updated with breaking news from Ohnson Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sen. Bernie Sanders is once again taking the pharmaceutical industry to task, issuing a report Tuesday that highlights the cost of three blockbuster drugs that are far pricier in the US than in other countries.
A new report released Tuesday by Sen. Bernie Sanders (I-Vt.) takes aim at the prices and executive compensation of three major drug manufacturers, previewing his lines of attack for when the companies’ CEOs appear at a hearing later this week. In the report prepared by Democratic staff on the Senate Health, Education, Labor and Pensions…
It's going to take a lot to interrupt these companies' streaks.
Since taking the helm of the committee that oversees the nation’s health care system last year, Senator Bernie Sanders has used his perch to take aim at pharmaceutical executives over the cost of prescription drugs. Next week, the CEOs of drug manufacturers Johnson & Johnson, Merck, and Bristol Myers Squibb will appear before the Health, Education, Labor and Pensions Committee to testify at a hearing concerned with the high prices of prescription medication in the United States as compared to ot
These industry-leading, time-tested companies are ideal for retired investors.